Deere rises after earnings, Amarin falls following FDA approval for generic equivalent to Vascepa Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Moderna (MRNA) up 3% after
Dr. Anthony Fauci said, in a CNN Town Hall, that positive early results from the Phase 1 study of the company's COVID-19 vaccine are a good sign
UP AFTER EARNINGS -
- Deere (DE) up 3%
- Pinduoduo (PDD) up 1%
- iClick Interactive Asia (ICLK) up 4%
- Teligent (TLGT) up 8%
- Palo Alto Networks (PANW) up 6%
- Nvidia (NVDA) up 1%
DOWN AFTER EARNINGS -
- Foot Locker (FL) down 7%
- Intuit (INTU) down 1%
- HP Enterprise (HPE) down 7%
ALSO LOWER -
- Syndax (SNDX) down 14% after announcing that its Phase 3 E2112 trial did not achieve the primary endpoint of demonstrating a statistically significant overall survival benefit over hormone therapy alone
- Roku (ROKU) down 2% after Stephens analyst Kyle Evans downgraded shares to Equal Weight from Overweight with a price target of $105, down from $155
- Amarin (AMRN) down 10% after Hikma Pharmaceuticals (HKMPF) announced that its wholly owned U.S. subsidiary has received approval from the FDA for its Icosapent Ethyl Capsules, the generic equivalent to Amarin's Vascepa
Symbols:
MRNA DE PDD ICLK TLGT PANW NVDA FL INTU HPE SNDX ROKU AMRN Keywords: Fly Intel, Wall Street, Top Stories, Stocks